Read + Share
Doi Y, Hamano T, Yamaguchi S, Sakaguchi Y, et al. Mediators between canagliflozin and renoprotection vary depending on patient
characteristics: Insights from the CREDENCE trial. Diabetes Obes Metab 2023;25:2944-2953.
PMID: 37385955
|
 |
|
Doi Y, Hamano T, Yamaguchi S, Sakaguchi Y, et al. Mediators between canagliflozin and renoprotection vary depending on patient
characteristics: Insights from the CREDENCE trial. Diabetes Obes Metab 2023;25:2944-2953.
PMID: 37385955
|
|
|
|